Stockscreener 앱 받기
2.92
3.18%
0.09
시간 외 거래:
2.88
-0.04
-1.37%
C 4 Therapeutics Inc 주식(CCCC)의 최신 뉴스
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
43 new Intellia employees get stock awards worth 208,850 shares - Stock Titan
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
C4 Therapeutics, Inc. (NASDAQ:CCCC) Short Interest Update - MarketBeat
C4 Therapeutics prices $125M equity offering with warrants - MSN
C4 Therapeutics (CCCC) to Release Quarterly Earnings on Wednesday - MarketBeat
Form ARS C4 Therapeutics, Inc. For: Apr 29 - StreetInsider
Form DEFA14A C4 Therapeutics, Inc. - StreetInsider
C4 Therapeutics (NASDAQ: CCCC) outlines 2026 votes and equity plan change - Stock Titan
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
C4 Therapeutics files $400M mixed shelf offering - MSN
CCCC stock gets pre-market boost on Roche tie-up to develop cancer treatments - MSN
[Form 4] Travere Therapeutics, Inc. Insider Trading Activity - Stock Titan
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics deepens Roche alliance to target breakthrough cancer therapies - MSN
CCCC (C4 Therapeutics Inc.) reports narrower than expected Q4 2025 loss, shares tick slightly higher in daily trading. - Cổng thông tin điện tử tỉnh Lào Cai
C4 Thera (CCCC) Stock Interest Rate (-2.88%) 2026-04-22Capital Preservation - UBND thành phố Hải Phòng
Wasatch holds 4.7% stake in C4 Therapeutics (CCCC) via Schedule 13G/A - Stock Titan
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - ChartMill
Assessing Roche Holding (SWX:ROG) Valuation After New C4 Therapeutics Oncology Partnership - Yahoo Finance
Atrium offers stock awards to 7 new hires under Nasdaq rule - Stock Titan
Analysts see significant upside in C4 Therapeutics (CCCC) stock - MSN
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Short Interest in C4 Therapeutics, Inc. (NASDAQ:CCCC) Grows By 19.4% - MarketBeat
C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
New PTC hire gets stock awards priced at $70.42 a share - Stock Titan
Stoke Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice - Eastern Progress
Acrivon Therapeutics announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 14, 2026 - BioSpace
Five new Travere hires get stock awards totaling 17,420 shares - Stock Titan
BridgeBio Oncology Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
CCCC Price Today: C4 Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
C4 Therapeutics Faces Ownership Changes Amidst Financial Declines - StocksToTrade
Travel Stocks: Can C4 Therapeutics Inc reach all time highs this year2026 Earnings & Safe Investment Capital Preservation Plans - baoquankhu1.vn
C4 Therapeutics Ownership Changes Raise Investor Concerns - timothysykes.com
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
C4 Therapeutics Amends By-laws to Designate Federal Courts as Exclusive Forum for Securities Act Claims - Minichart
C4 Therapeutics updates bylaws to designate federal courts as exclusive forums - Investing.com
C4 Therapeutics (NASDAQ: CCCC) narrows forums for securities lawsuits - Stock Titan
Roche and C4 Therapeutics to advance degrader-antibody conjugates research - Yahoo Finance
2.45%
자본화:
|
볼륨(24시간):